Michael Scolaro

Michael Scolaro

Oct 08, 2017

Group 6 Copy 156
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Circulating biomarkers of fibrosis in captive gorillas: a pilot study

Heart disease is the leading cause of death for gorillas in captivity. The ultimate goal of this project...

A Leap Forward to Cure a Neglected Disease

The World Health Organization estimates that as many as 11 million people worldwide are infected with the...

Are Emergency Doctors Uncomfortable Treating Patients in Psychiatric Crisis? If so, Why?

This survey research study aims to explore the amount of confidence emergency physicians have with treating...

Backer Badge Funded